Response to Letter to the Editor from Dr. Paul et al

Authors

Jonathan I. Silverberg, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA.
Liliana Ulianov, Galderma R&D, Lausanne, Switzerland.
Christophe Piketty, Galderma R&D, Zug, Switzerland.

Document Type

Letter to the Editor

Publication Date

12-4-2025

Journal

Journal of the European Academy of Dermatology and Venereology : JEADV

DOI

10.1111/jdv.70242

Keywords

IL‐31; adolescent; adult; atopic dermatitis; nemolizumab; pruritus

APA Citation

Silverberg, Jonathan I.; Ulianov, Liliana; and Piketty, Christophe, "Response to Letter to the Editor from Dr. Paul et al" (2025). GW Authored Works. Paper 8442.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8442

Department

Dermatology